is zepbound better than compound tirzepatide vs. Semaglutide for Weight Loss Zepbound (Tirzepatide) was just FDA-approved

One of the top reasons why retatrutide is coming up on the news is because unlike the previous obesity injectibles which are dual-agonist, retatrutide is triple-agonist

Y., Ahmad, N

This applies to: 503A compounders: Until April 22, 2025 503B facilities: Until May 22, 2025 Important Caveat: The FDA may still take action regarding violations of any other statutory or regulatory requirements, such as to address findings that a product may be of substandard quality or otherwise unsafe

That moment of doubt can feel surprisingly stressful

Pregnancy and breastfeeding: Tirzepatide is not recommended during pregnancy and breastfeeding, and the drug should be discontinued at least one month before women attempt to conceive

I highly recommend it Easy to use platform and communication